植入性老视眼角膜内镜片术后角膜雾翳的介质。
Mediators of Corneal Haze Following Implantation of Presbyopic Corneal Inlays.
机构信息
Singapore National Eye Centre, Singapore.
Singapore Eye Research Institute, Singapore.
出版信息
Invest Ophthalmol Vis Sci. 2019 Mar 1;60(4):868-876. doi: 10.1167/iovs.18-25761.
PURPOSE
To identify protein mediators of corneal haze following presbyopic corneal inlay surgery.
METHODS
Tears were collected from eyes with corneal haze following surgery with a shape-changing corneal inlay. Samples were subjected to quantitative proteomic analysis using iTRAQ and proteins significantly increased or decreased (1.3-fold or more) in haze eyes relative to fellow eyes were identified. Expression ratios were compared to postoperative eyes without corneal haze to identify proteins selectively increased or decreased in corneal haze eyes.
RESULTS
Inlay-associated haze occurred in 35% of eyes (6 of 17). Of 1443 unique tear proteins identified, eight proteins were selectively reduced in tears from postoperative haze eyes and one protein selectively increased. Proteins reduced in haze eyes included complement 4a (level relative to nonhaze eyes 0.464, P = 0.037), complement factor H (0.589, P = 0.048), immunoglobulin kappa variable 2-29 (0.128, P = 0.006), immunoglobulin kappa variable 2D-28 (0.612, P = 0.025), immunoglobulin lambda variable 7-46 (0.482, P = 0.007), S100 calcium binding protein A4 (0.614, P = 0.048), Shootin-1 (0.614, P = 0.048), and tissue inhibitor of metalloproteinase-1 (0.736, P = 0.023). The Xaa-Pro aminopeptidase 1 was increased in haze eyes relative to nonhaze eyes (1.517, P = 0.023).
CONCLUSIONS
Corneal haze following corneal inlay surgery is associated with reduction in levels of known inflammatory and immune mediators. These findings represent a starting point for elucidation of pathways involved in corneal haze following synthetic inlay implantation and may enable development of targeted therapies that modulate the haze response.
目的
鉴定老视眼角膜内植入术后角膜混浊的蛋白介质。
方法
收集接受形状记忆角膜内植入术后发生角膜混浊的眼的泪液。采用 iTRAQ 进行定量蛋白质组学分析,鉴定出与对照眼相比在混浊眼中显著增加或减少(增加或减少 1.3 倍以上)的蛋白。将表达比值与术后无角膜混浊的眼进行比较,以鉴定选择性增加或减少在角膜混浊眼中的蛋白。
结果
17 只眼中有 35%(6 只)发生内植入物相关混浊。在鉴定的 1443 种独特的泪液蛋白中,有 8 种蛋白在术后混浊眼中的泪液中选择性减少,有一种蛋白选择性增加。在混浊眼中减少的蛋白包括补体 4a(与非混浊眼相比的相对水平为 0.464,P=0.037)、补体因子 H(0.589,P=0.048)、免疫球蛋白κ轻链可变 2-29(0.128,P=0.006)、免疫球蛋白κ轻链可变 2D-28(0.612,P=0.025)、免疫球蛋白λ轻链可变 7-46(0.482,P=0.007)、S100 钙结合蛋白 A4(0.614,P=0.048)、Shootin-1(0.614,P=0.048)和金属蛋白酶组织抑制剂 1(0.736,P=0.023)。Xaa-Pro 氨肽酶 1 在混浊眼中的含量高于非混浊眼中(1.517,P=0.023)。
结论
角膜内植入术后角膜混浊与已知炎症和免疫介质水平降低有关。这些发现为阐明合成内植入物植入后角膜混浊的相关途径提供了起点,并可能为开发靶向治疗方法提供了可能,从而调节混浊反应。